Advanced Cancers: KFA115 Treatment Study

We are exploring a new drug, KFA115, alone and with pembrolizumab for patients with advanced cancers. The goal is to understand its safety and how well it works.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Leon Berard
#1001:Oncology
Meyzieu, France
Institut Gustave Roussy
#1000:Oncology
Villejuif, France
Technische Universitat Dresden
#1501: Medizinische Klinik und Poliklinik I
Dresden, Germany

Sponsor: Novartis Pharma AG
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.